Drawing for PHARMACO WIRING

USPTO serial 78175019

PHARMACO WIRING

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
FLETCHER, TRACY L
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PHARMACO WIRING?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Charles E. Weinstein, Esq.

CHARLES E WEINSTEIN ESQ FOLEY HOAG LLPWORLD TRADE CTR W155 SEAPORT BLVDBOSTON, MA 02210-2600

Goods and services

ClassDescriptionStatusFirst use
042Research and development in the field of pharmacy and pharmacology, biotechnological and molecularbiological basic research.; Research and development in the field of pharmacy and pharmacology, biotechnological and molecularbiological basic research.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 23, 2003ABN1ABANDONMENT - EXPRESS MAILED—
Aug 23, 2003ZZZYPREVIOUS ACTION COUNT WITHDRAWN—
Aug 14, 2003CFITCASE FILE IN TICRS—
Jul 25, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 25, 2003MAILPAPER RECEIVED—
Apr 7, 2003CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 24, 2003DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance